Bilaketaren emaitzak - Isabelle Borget

Findu emaitzak
  1. 1
    Suitability of the Current Health Technology Assessment of Innovative Artificial Intelligence-Based Medical Devices: Scoping Literature Review

    Suitability of the Current Health Technology Assessment of Innovative Artificial Intelligence-Based Medical Devices: Scoping Literature Review nork Line Farah, Isabelle Borget, Nicolas Martelli, Alexandre Vallée

    Argitaratua 2024
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  2. 2
    Are current clinical studies on artificial intelligence-based medical devices comprehensive enough to support a full health technology assessment? A systematic review

    Are current clinical studies on artificial intelligence-based medical devices comprehensive enough to support a full health technology assessment? A systematic review nork Line Farah, Julie Davaze-Schneider, Tess Martin, Pierre Nguyen, Isabelle Borget, Nicolas Martelli

    Argitaratua 2023
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  3. 3
    Assessment of the Cost of Fine-Needle Aspiration Cytology as a Diagnostic Tool in Patients With Thyroid Nodules

    Assessment of the Cost of Fine-Needle Aspiration Cytology as a Diagnostic Tool in Patients With Thyroid Nodules nork Isabelle Borget, Philippe Vielh, Sophie Leboulleux, Mark Allyn, Sylviane Iacobelli, Martin Schlumberger, Gérard de Pouvourville

    Argitaratua 2008
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  4. 4
    <sup>131</sup>I Effective Half-Life and Dosimetry in Thyroid Cancer Patients

    <sup>131</sup>I Effective Half-Life and Dosimetry in Thyroid Cancer Patients nork Hervé Remy, Isabelle Borget, Sophie Leboulleux, Nadine Guilabert, F. Lavielle, Jérome Garsi, Claire Bournaud, Séverine Gupta, Martin Schlumberger, Marcel Ricard

    Argitaratua 2008
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  5. 5
    Body Composition Variation and Impact of Low Skeletal Muscle Mass in Patients With Advanced Medullary Thyroid Carcinoma Treated With Vandetanib: Results From a Placebo-Controlled Study

    Body Composition Variation and Impact of Low Skeletal Muscle Mass in Patients With Advanced Medullary Thyroid Carcinoma Treated With Vandetanib: Results From a Placebo-Controlled S... nork Marie-Hélène Massicotte, Isabelle Borget, Sophie Broutin, Vickie E. Baracos, Sophie Leboulleux, Éric Baudin, Angélo Paci, Alain Deroussent, Martin Schlumberger, S. Antoun

    Argitaratua 2013
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  6. 6
    Endocrine Effects of the Tyrosine Kinase Inhibitor Vandetanib in Patients Treated for Thyroid Cancer

    Endocrine Effects of the Tyrosine Kinase Inhibitor Vandetanib in Patients Treated for Thyroid Cancer nork Maryse Brassard, B. Néraud, Séverine Trabado, Sylvie Salenave, Sylvie Brailly‐Tabard, Isabelle Borget, Éric Baudin, Sophie Leboulleux, Philippe Chanson, Martin Schlumberger, Jacques Young

    Argitaratua 2011
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  7. 7
    Ultrasensitive serum thyroglobulin measurement is useful for the follow-up of patients treated with total thyroidectomy without radioactive iodine ablation

    Ultrasensitive serum thyroglobulin measurement is useful for the follow-up of patients treated with total thyroidectomy without radioactive iodine ablation nork C. Nascimento, Isabelle Borget, Frédéric Troalen, Abir Al Ghuzlan, Désirèe Deandreis, Dana M. Hartl, J. Lumbroso, C. Chougnet, Éric Baudin, M. Schlumberger, Sophie Leboulleux

    Argitaratua 2013
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  8. 8
    High-dose mitotane strategy in adrenocortical carcinoma: prospective analysis of plasma mitotane measurement during the first 3 months of follow-up

    High-dose mitotane strategy in adrenocortical carcinoma: prospective analysis of plasma mitotane measurement during the first 3 months of follow-up nork Sophie Giraud, Sophie Leboulleux, Isabelle Borget, Angélo Paci, Jacques Young, Abir Al Ghuzlan, Désirèe Deandreis, Laurence Drouard, Antoine Tabarin, Philippe Chanson, Martin Schlumberger, Éric Baudin

    Argitaratua 2011
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  9. 9
    Cost of cancer diagnosis using next-generation sequencing targeted gene panels in routine practice: a nationwide French study

    Cost of cancer diagnosis using next-generation sequencing targeted gene panels in routine practice: a nationwide French study nork Patricia Marino, Rajae Touzani, Lionel Perrier, Étienne Rouleau, Dede Sika Kossi, Zhaomin Zou, Nathanaël Charrier, Nicolas Goardon, Claude Preudhomme, Isabelle Durand‐Zaleski, Isabelle Borget, Sandrine Baffert

    Argitaratua 2018
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  10. 10
    High level of chromosomal instability in circulating tumor cells of ROS1-rearranged non-small-cell lung cancer

    High level of chromosomal instability in circulating tumor cells of ROS1-rearranged non-small-cell lung cancer nork Emma Pailler, Nathalie Auger, Colin R. Lindsay, Philippe Vielh, A. Islas-Morris-Hernandez, Isabelle Borget, Maud Ngo‐Camus, David Planchard, Jean‐Charles Soria, B. Besse, F Farace

    Argitaratua 2015
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  11. 11
    Surgery for Neck Recurrence of Differentiated Thyroid Cancer: Outcomes and Risk Factors

    Surgery for Neck Recurrence of Differentiated Thyroid Cancer: Outcomes and Risk Factors nork Livia Lamartina, Isabelle Borget, H. Mirghani, Abir Al Ghuzlan, A. Berdelou, François Bidault, Désirèe Deandreis, Éric Baudin, Jean‐Paul Travagli, Martin Schlumberger, Dana M. Hartl, Sophie Leboulleux

    Argitaratua 2017
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  12. 12
    Persistent disease and recurrence in differentiated thyroid cancer patients with undetectable postoperative stimulated thyroglobulin level

    Persistent disease and recurrence in differentiated thyroid cancer patients with undetectable postoperative stimulated thyroglobulin level nork C. Nascimento, Isabelle Borget, Abir Al Ghuzlan, Désirèe Deandreis, L. Chami, J P Travagli, Dana M. Hartl, J. Lumbroso, C. Chougnet, Ludovic Lacroix, Éric Baudin, Martin Schlumberger, Sophie Leboulleux

    Argitaratua 2010
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  13. 13
    Detection of Circulating Tumor Cells Harboring a Unique <i>ALK</i> Rearrangement in <i>ALK</i>-Positive Non–Small-Cell Lung Cancer

    Detection of Circulating Tumor Cells Harboring a Unique <i>ALK</i> Rearrangement in <i>ALK</i>-Positive Non–Small-Cell Lung Cancer nork Emma Pailler, Julien Adam, Amélie Barthelemy, Marianne Oulhen, Nathalie Auger, Alexander Valent, Isabelle Borget, David Planchard, Mélissa Taylor, Fabrice André, Jean Charles Soria, Philippe Vielh, Benjamin Besse, Françoise Farace

    Argitaratua 2013
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  14. 14
    Tyrosine kinase inhibitor treatments in patients with metastatic thyroid carcinomas: a retrospective study of the TUTHYREF network

    Tyrosine kinase inhibitor treatments in patients with metastatic thyroid carcinomas: a retrospective study of the TUTHYREF network nork Marie-Hélène Massicotte, Maryse Brassard, M. Claude-Desroches, Isabelle Borget, F. Bonichon, Anne‐Laure Giraudet, Christine Do Cao, C. Chougnet, Sophie Leboulleux, Éric Baudin, Martin Schlumberger, Christelle de la Fouchardière

    Argitaratua 2014
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  15. 15
    Antiangiogenic Tyrosine Kinase Inhibitors: Occurrence and Risk Factors of Hemoptysis in Refractory Thyroid Cancer

    Antiangiogenic Tyrosine Kinase Inhibitors: Occurrence and Risk Factors of Hemoptysis in Refractory Thyroid Cancer nork Livia Lamartina, Serena Ippolito, Marion Danis, François Bidault, Isabelle Borget, A. Berdelou, Abir Al Ghuzlan, Dana M. Hartl, Pierre Blanchard, M. Terroir, Désirèe Deandreis, Martin Schlumberger, Éric Baudin, Sophie Leboulleux

    Argitaratua 2016
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  16. 16
    Circulating Tumor Cells with Aberrant <i>ALK</i> Copy Number Predict Progression-Free Survival during Crizotinib Treatment in <i>ALK</i>-Rearranged Non–Small Cell Lung Cancer Patients

    Circulating Tumor Cells with Aberrant <i>ALK</i> Copy Number Predict Progression-Free Survival during Crizotinib Treatment in <i>ALK</i>-Rearranged Non–Small Cell Lung Cancer Patie... nork Emma Pailler, Marianne Oulhen, Isabelle Borget, Jordi Remón, Kirsty Ross, Nathalie Auger, Fanny Billiot, Maud Ngo Camus, Frédéric Commo, Colin R. Lindsay, David Planchard, Jean‐Charles Soria, Benjamin Besse, Françoise Farace

    Argitaratua 2017
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  17. 17
    Long-Term Follow-Up of Patients with Papillary and Follicular Thyroid Cancer: A Prospective Study on 715 Patients

    Long-Term Follow-Up of Patients with Papillary and Follicular Thyroid Cancer: A Prospective Study on 715 Patients nork Maryse Brassard, Isabelle Borget, Agathe Edet‐Sanson, Anne‐Laure Giraudet, O. Mundler, Michel Toubeau, F. Bonichon, Françoise Borson‐Chazot, Laurence Leenhardt, Claire Schvartz, C. Dejax, Isabelle Brenot‐Rossi, Marie‐Elisabeth Toubert, Massimo Torlontano, E Benhamou, Martin Schlumberger

    Argitaratua 2011
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  18. 18
    Post-first-line FOLFOX chemotherapy for grade 3 neuroendocrine carcinoma

    Post-first-line FOLFOX chemotherapy for grade 3 neuroendocrine carcinoma nork Julien Hadoux, David Malka, David Planchard, Jean–Yves Scoazec, Caroline Caramella, J. Guigay, Valérie Boige, Sophie Leboulleux, Pascal Burtin, A. Berdelou, Yohann Loriot, Pierre Duvillard, C. Chougnet, Désirèe Deandreis, Martin Schlumberger, Isabelle Borget, Michel Ducreux, Éric Baudin

    Argitaratua 2015
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  19. 19
    Strategies of Radioiodine Ablation in Patients with Low-Risk Thyroid Cancer

    Strategies of Radioiodine Ablation in Patients with Low-Risk Thyroid Cancer nork Martin Schlumberger, Bogdan Catargi, Isabelle Borget, Désirèe Deandreis, Slimane Zerdoud, B. Bridji, Stéphane Bardet, Laurence Leenhardt, D. Bastié, Claire Schvartz, Pierre Véra, Olivier Morel, Danielle Benisvy, Claire Bournaud, Franccoise Bonichon, C. Dejax, Marie‐Elisabeth Toubert, Sophie Leboulleux, Marcel Ricard, E Benhamou

    Argitaratua 2012
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  20. 20
    Quality of Life and Cost-Effectiveness Assessment of Radioiodine Ablation Strategies in Patients With Thyroid Cancer: Results From the Randomized Phase III ESTIMABL Trial

    Quality of Life and Cost-Effectiveness Assessment of Radioiodine Ablation Strategies in Patients With Thyroid Cancer: Results From the Randomized Phase III ESTIMABL Trial nork Isabelle Borget, Julia Bonastre, Bogdan Catargi, Désirèe Deandreis, Slimane Zerdoud, Daniéla Rusu, Stéphane Bardet, Laurence Leenhardt, D. Bastié, Claire Schvartz, Pierre Véra, Olivier Morel, D. Benisvy, Claire Bournaud, F. Bonichon, A. Kelly, Marie-Elisabeth Toubert, Sophie Leboulleux, Florence Journeau, E Benhamou, Martin Schlumberger

    Argitaratua 2015
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:

Bilaketa egiteko lanabesak: